|
|
||||||||
1 Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Baltimore, MD 21205, USA
2 Clinical Mycobacteriology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
Correspondence
Ying Zhang
yzhang{at}jhsph.edu
Received 11 May 2006
Accepted 3 August 2006
T and was present in 13 of the 17 inhA mutations. This promoter mutation occurred alone without katG mutations and was associated with a low level of INH and ethionamide resistance. However, other inhA mutations were associated with katG mutations. No mutations were found in the ndh gene. Three of 33 strains (9 %) had no mutations in katG, inhA or ndh, indicating that their resistance was due to a new mechanism of resistance. Detection of the KatG Ser315Thr mutation and the 15C
T inhA mutation accounted for 76 % (25/33) of the INH-resistant strains and should be useful for rapid detection of INH-resistant strains by molecular tests.
Abbreviations: ETH, ethionamide; INH, isoniazid.
This article has been cited by other articles:
![]() |
I. L. Bergval, A. R. J. Schuitema, P. R. Klatser, and R. M. Anthony Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance J. Antimicrob. Chemother., September 1, 2009; 64(3): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ho, Y.-J. Sun, S.-Y. Wong, and A. S. G. Lee Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates Antimicrob. Agents Chemother., September 1, 2009; 53(9): 4010 - 4012. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |